“Experimental Alzheimer's drug shows promise”
A clinical trial is now underway to test a new drug that shows promise for slowing the relentless progression of memory loss and mental decline in Alzheimer's patients. The drug is called T-817MA and it's designed to protect nerve cells in the brain. Learn more

Mount Sinai Implements Own the Bone® Program for Fragility Fracture Patients
Jul 08, 2025 View All Press Releases
Mount Sinai Establishes Steven S. Elbaum Family Center for Caregiving
May 20, 2025 View All Press Releases
Mount Sinai Surgeons Perform First Heart-Liver-Kidney Transplants in New York State
May 20, 2025 View All Press Releases